Copyright Reports & Markets. All rights reserved.

Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Report 2021

Request for Sample of this report
Buy now

1 Angiotensin Converting Enzyme (ACE) Inhibitors Market Overview

  • 1.1 Angiotensin Converting Enzyme (ACE) Inhibitors Product Scope
  • 1.2 Angiotensin Converting Enzyme (ACE) Inhibitors Segment by Type
    • 1.2.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Type (2016 & 2021 & 2027)
    • 1.2.2 Sulfhydryl-containing Agents
    • 1.2.3 Dicarboxylate-containing Agents
    • 1.2.4 Phosphonate-containing Agents
  • 1.3 Angiotensin Converting Enzyme (ACE) Inhibitors Segment by Application
    • 1.3.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Comparison by Application (2016 & 2021 & 2027)
    • 1.3.2 Hypertension
    • 1.3.3 Cardiovascular Diseases
    • 1.3.4 Kidney Diseases
    • 1.3.5 Other
  • 1.4 Angiotensin Converting Enzyme (ACE) Inhibitors Market Estimates and Forecasts (2016-2027)
    • 1.4.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Size in Value Growth Rate (2016-2027)
    • 1.4.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Size in Volume Growth Rate (2016-2027)
    • 1.4.3 Global Angiotensin Converting Enzyme (ACE) Inhibitors Price Trends (2016-2027)

2 Angiotensin Converting Enzyme (ACE) Inhibitors Estimates and Forecasts by Region

  • 2.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Size by Region: 2016 VS 2021 VS 2027
  • 2.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Retrospective Market Scenario by Region (2016-2021)
    • 2.2.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Region (2016-2021)
    • 2.2.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share by Region (2016-2021)
  • 2.3 Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Estimates and Forecasts by Region (2022-2027)
    • 2.3.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Estimates and Forecasts by Region (2022-2027)
    • 2.3.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Forecast by Region (2022-2027)
  • 2.4 Geographic Market Analysis: Market Facts & Figures
    • 2.4.1 North America Angiotensin Converting Enzyme (ACE) Inhibitors Estimates and Projections (2016-2027)
    • 2.4.2 Europe Angiotensin Converting Enzyme (ACE) Inhibitors Estimates and Projections (2016-2027)
    • 2.4.3 China Angiotensin Converting Enzyme (ACE) Inhibitors Estimates and Projections (2016-2027)
    • 2.4.4 Japan Angiotensin Converting Enzyme (ACE) Inhibitors Estimates and Projections (2016-2027)
    • 2.4.5 Southeast Asia Angiotensin Converting Enzyme (ACE) Inhibitors Estimates and Projections (2016-2027)
    • 2.4.6 India Angiotensin Converting Enzyme (ACE) Inhibitors Estimates and Projections (2016-2027)

3 Global Angiotensin Converting Enzyme (ACE) Inhibitors Competition Landscape by Players

  • 3.1 Global Top Angiotensin Converting Enzyme (ACE) Inhibitors Players by Sales (2016-2021)
  • 3.2 Global Top Angiotensin Converting Enzyme (ACE) Inhibitors Players by Revenue (2016-2021)
  • 3.3 Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Angiotensin Converting Enzyme (ACE) Inhibitors as of 2020)
  • 3.4 Global Angiotensin Converting Enzyme (ACE) Inhibitors Average Price by Company (2016-2021)
  • 3.5 Manufacturers Angiotensin Converting Enzyme (ACE) Inhibitors Manufacturing Sites, Area Served, Product Type
  • 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Size by Type

  • 4.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Historic Market Review by Type (2016-2021)
    • 4.1.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Type (2016-2021)
    • 4.1.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share by Type (2016-2021)
    • 4.1.3 Global Angiotensin Converting Enzyme (ACE) Inhibitors Price by Type (2016-2021)
  • 4.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Estimates and Forecasts by Type (2022-2027)
    • 4.2.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Forecast by Type (2022-2027)
    • 4.2.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Forecast by Type (2022-2027)
    • 4.2.3 Global Angiotensin Converting Enzyme (ACE) Inhibitors Price Forecast by Type (2022-2027)

5 Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Size by Application

  • 5.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Historic Market Review by Application (2016-2021)
    • 5.1.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Application (2016-2021)
    • 5.1.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share by Application (2016-2021)
    • 5.1.3 Global Angiotensin Converting Enzyme (ACE) Inhibitors Price by Application (2016-2021)
  • 5.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Estimates and Forecasts by Application (2022-2027)
    • 5.2.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Forecast by Application (2022-2027)
    • 5.2.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Forecast by Application (2022-2027)
    • 5.2.3 Global Angiotensin Converting Enzyme (ACE) Inhibitors Price Forecast by Application (2022-2027)

6 North America Angiotensin Converting Enzyme (ACE) Inhibitors Market Facts & Figures

  • 6.1 North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Company
    • 6.1.1 North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Company (2016-2021)
    • 6.1.2 North America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Company (2016-2021)
  • 6.2 North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Breakdown by Type
    • 6.2.1 North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Breakdown by Type (2016-2021)
    • 6.2.2 North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Breakdown by Type (2022-2027)
  • 6.3 North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Breakdown by Application
    • 6.3.1 North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Breakdown by Application (2016-2021)
    • 6.3.2 North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Breakdown by Application (2022-2027)

7 Europe Angiotensin Converting Enzyme (ACE) Inhibitors Market Facts & Figures

  • 7.1 Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Company
    • 7.1.1 Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Company (2016-2021)
    • 7.1.2 Europe Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Company (2016-2021)
  • 7.2 Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales Breakdown by Type
    • 7.2.1 Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales Breakdown by Type (2016-2021)
    • 7.2.2 Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales Breakdown by Type (2022-2027)
  • 7.3 Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales Breakdown by Application
    • 7.3.1 Europe 134 Sales Breakdown by Application (2016-2021)
    • 7.3.2 Europe 134 Sales Breakdown by Application (2022-2027)

8 China Angiotensin Converting Enzyme (ACE) Inhibitors Market Facts & Figures

  • 8.1 China Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Company
    • 8.1.1 China Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Company (2016-2021)
    • 8.1.2 China Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Company (2016-2021)
  • 8.2 China Angiotensin Converting Enzyme (ACE) Inhibitors Sales Breakdown by Type
    • 8.2.1 China Angiotensin Converting Enzyme (ACE) Inhibitors Sales Breakdown by Type (2016-2021)
    • 8.2.2 China Angiotensin Converting Enzyme (ACE) Inhibitors Sales Breakdown by Type (2022-2027)
  • 8.3 China Angiotensin Converting Enzyme (ACE) Inhibitors Sales Breakdown by Application
    • 8.3.1 China 152 Sales Breakdown by Application (2016-2021)
    • 8.3.2 China 152 Sales Breakdown by Application (2022-2027)

9 Japan Angiotensin Converting Enzyme (ACE) Inhibitors Market Facts & Figures

  • 9.1 Japan Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Company
    • 9.1.1 Japan Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Company (2016-2021)
    • 9.1.2 Japan Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Company (2016-2021)
  • 9.2 Japan Angiotensin Converting Enzyme (ACE) Inhibitors Sales Breakdown by Type
    • 9.2.1 Japan Angiotensin Converting Enzyme (ACE) Inhibitors Sales Breakdown by Type (2016-2021)
    • 9.2.2 Japan Angiotensin Converting Enzyme (ACE) Inhibitors Sales Breakdown by Type (2022-2027)
  • 9.3 Japan Angiotensin Converting Enzyme (ACE) Inhibitors Sales Breakdown by Application
    • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
    • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Angiotensin Converting Enzyme (ACE) Inhibitors Market Facts & Figures

  • 10.1 Southeast Asia Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Company
    • 10.1.1 Southeast Asia Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Company (2016-2021)
    • 10.1.2 Southeast Asia Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Company (2016-2021)
  • 10.2 Southeast Asia Angiotensin Converting Enzyme (ACE) Inhibitors Sales Breakdown by Type
    • 10.2.1 Southeast Asia Angiotensin Converting Enzyme (ACE) Inhibitors Sales Breakdown by Type (2016-2021)
    • 10.2.2 Southeast Asia Angiotensin Converting Enzyme (ACE) Inhibitors Sales Breakdown by Type (2022-2027)
  • 10.3 Southeast Asia Angiotensin Converting Enzyme (ACE) Inhibitors Sales Breakdown by Application
    • 10.3.1 Southeast Asia K MT Sales Breakdown by Application (2016-2021)
    • 10.3.2 Southeast Asia K MT Sales Breakdown by Application (2022-2027)

11 India Angiotensin Converting Enzyme (ACE) Inhibitors Market Facts & Figures

  • 11.1 India Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Company
    • 11.1.1 India Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Company (2016-2021)
    • 11.1.2 India Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Company (2016-2021)
  • 11.2 India Angiotensin Converting Enzyme (ACE) Inhibitors Sales Breakdown by Type
    • 11.2.1 India Angiotensin Converting Enzyme (ACE) Inhibitors Sales Breakdown by Type (2016-2021)
    • 11.2.2 India Angiotensin Converting Enzyme (ACE) Inhibitors Sales Breakdown by Type (2022-2027)
  • 11.3 India Angiotensin Converting Enzyme (ACE) Inhibitors Sales Breakdown by Application
    • 11.3.1 India Angiotensin Converting Enzyme (ACE) Inhibitors Sales Breakdown by Application (2016-2021)
    • 11.3.2 India Angiotensin Converting Enzyme (ACE) Inhibitors Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Angiotensin Converting Enzyme (ACE) Inhibitors Business

  • 12.1 Abbott Laboratories
    • 12.1.1 Abbott Laboratories Corporation Information
    • 12.1.2 Abbott Laboratories Business Overview
    • 12.1.3 Abbott Laboratories Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Revenue and Gross Margin (2016-2021)
    • 12.1.4 Abbott Laboratories Angiotensin Converting Enzyme (ACE) Inhibitors Products Offered
    • 12.1.5 Abbott Laboratories Recent Development
  • 12.2 Pfizer
    • 12.2.1 Pfizer Corporation Information
    • 12.2.2 Pfizer Business Overview
    • 12.2.3 Pfizer Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Revenue and Gross Margin (2016-2021)
    • 12.2.4 Pfizer Angiotensin Converting Enzyme (ACE) Inhibitors Products Offered
    • 12.2.5 Pfizer Recent Development
  • 12.3 Novartis
    • 12.3.1 Novartis Corporation Information
    • 12.3.2 Novartis Business Overview
    • 12.3.3 Novartis Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Revenue and Gross Margin (2016-2021)
    • 12.3.4 Novartis Angiotensin Converting Enzyme (ACE) Inhibitors Products Offered
    • 12.3.5 Novartis Recent Development
  • 12.4 Merck
    • 12.4.1 Merck Corporation Information
    • 12.4.2 Merck Business Overview
    • 12.4.3 Merck Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Revenue and Gross Margin (2016-2021)
    • 12.4.4 Merck Angiotensin Converting Enzyme (ACE) Inhibitors Products Offered
    • 12.4.5 Merck Recent Development
  • 12.5 Astra Zeneca
    • 12.5.1 Astra Zeneca Corporation Information
    • 12.5.2 Astra Zeneca Business Overview
    • 12.5.3 Astra Zeneca Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Revenue and Gross Margin (2016-2021)
    • 12.5.4 Astra Zeneca Angiotensin Converting Enzyme (ACE) Inhibitors Products Offered
    • 12.5.5 Astra Zeneca Recent Development
  • 12.6 Jhonson and Johnson
    • 12.6.1 Jhonson and Johnson Corporation Information
    • 12.6.2 Jhonson and Johnson Business Overview
    • 12.6.3 Jhonson and Johnson Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Revenue and Gross Margin (2016-2021)
    • 12.6.4 Jhonson and Johnson Angiotensin Converting Enzyme (ACE) Inhibitors Products Offered
    • 12.6.5 Jhonson and Johnson Recent Development
  • 12.7 Eli Lilly
    • 12.7.1 Eli Lilly Corporation Information
    • 12.7.2 Eli Lilly Business Overview
    • 12.7.3 Eli Lilly Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Revenue and Gross Margin (2016-2021)
    • 12.7.4 Eli Lilly Angiotensin Converting Enzyme (ACE) Inhibitors Products Offered
    • 12.7.5 Eli Lilly Recent Development
  • 12.8 Sanofi
    • 12.8.1 Sanofi Corporation Information
    • 12.8.2 Sanofi Business Overview
    • 12.8.3 Sanofi Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Revenue and Gross Margin (2016-2021)
    • 12.8.4 Sanofi Angiotensin Converting Enzyme (ACE) Inhibitors Products Offered
    • 12.8.5 Sanofi Recent Development
  • 12.9 Bristol-Myers Squibb
    • 12.9.1 Bristol-Myers Squibb Corporation Information
    • 12.9.2 Bristol-Myers Squibb Business Overview
    • 12.9.3 Bristol-Myers Squibb Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Revenue and Gross Margin (2016-2021)
    • 12.9.4 Bristol-Myers Squibb Angiotensin Converting Enzyme (ACE) Inhibitors Products Offered
    • 12.9.5 Bristol-Myers Squibb Recent Development
  • 12.10 Bayer
    • 12.10.1 Bayer Corporation Information
    • 12.10.2 Bayer Business Overview
    • 12.10.3 Bayer Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Revenue and Gross Margin (2016-2021)
    • 12.10.4 Bayer Angiotensin Converting Enzyme (ACE) Inhibitors Products Offered
    • 12.10.5 Bayer Recent Development
  • 12.11 GSK
    • 12.11.1 GSK Corporation Information
    • 12.11.2 GSK Business Overview
    • 12.11.3 GSK Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Revenue and Gross Margin (2016-2021)
    • 12.11.4 GSK Angiotensin Converting Enzyme (ACE) Inhibitors Products Offered
    • 12.11.5 GSK Recent Development
  • 12.12 Teva Pharmaceutical
    • 12.12.1 Teva Pharmaceutical Corporation Information
    • 12.12.2 Teva Pharmaceutical Business Overview
    • 12.12.3 Teva Pharmaceutical Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Revenue and Gross Margin (2016-2021)
    • 12.12.4 Teva Pharmaceutical Angiotensin Converting Enzyme (ACE) Inhibitors Products Offered
    • 12.12.5 Teva Pharmaceutical Recent Development

13 Angiotensin Converting Enzyme (ACE) Inhibitors Manufacturing Cost Analysis

  • 13.1 Angiotensin Converting Enzyme (ACE) Inhibitors Key Raw Materials Analysis
    • 13.1.1 Key Raw Materials
    • 13.1.2 Key Raw Materials Price Trend
    • 13.1.3 Key Suppliers of Raw Materials
  • 13.2 Proportion of Manufacturing Cost Structure
  • 13.3 Manufacturing Process Analysis of Angiotensin Converting Enzyme (ACE) Inhibitors
  • 13.4 Angiotensin Converting Enzyme (ACE) Inhibitors Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

  • 14.1 Marketing Channel
  • 14.2 Angiotensin Converting Enzyme (ACE) Inhibitors Distributors List
  • 14.3 Angiotensin Converting Enzyme (ACE) Inhibitors Customers

15 Market Dynamics

  • 15.1 Angiotensin Converting Enzyme (ACE) Inhibitors Market Trends
  • 15.2 Angiotensin Converting Enzyme (ACE) Inhibitors Drivers
  • 15.3 Angiotensin Converting Enzyme (ACE) Inhibitors Market Challenges
  • 15.4 Angiotensin Converting Enzyme (ACE) Inhibitors Market Restraints

16 Research Findings and Conclusion

    17 Appendix

    • 17.1 Research Methodology
      • 17.1.1 Methodology/Research Approach
      • 17.1.2 Data Source
    • 17.2 Author List

    The global Angiotensin Converting Enzyme (ACE) Inhibitors market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Angiotensin Converting Enzyme (ACE) Inhibitors market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

    Segment by Type
    Sulfhydryl-containing Agents
    Dicarboxylate-containing Agents
    Phosphonate-containing Agents

    Segment by Application
    Hypertension
    Cardiovascular Diseases
    Kidney Diseases
    Other

    The Angiotensin Converting Enzyme (ACE) Inhibitors market is analysed and market size information is provided by regions (countries). Segment by Application, the Angiotensin Converting Enzyme (ACE) Inhibitors market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

    By Company
    Abbott Laboratories
    Pfizer
    Novartis
    Merck
    Astra Zeneca
    Jhonson and Johnson
    Eli Lilly
    Sanofi
    Bristol-Myers Squibb
    Bayer
    GSK
    Teva Pharmaceutical

    Buy now